First-in-Human Study for a Selective Rearranged During Transfection Tyrosine Kinase Inhibitor, GSK3352589, to Investigate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers.
Clin Pharmacol Drug Dev
; 10(4): 334-345, 2021 04.
Article
en En
| MEDLINE
| ID: mdl-33606922
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Interacciones Alimento-Droga
/
Inhibidores de Proteínas Quinasas
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Clin Pharmacol Drug Dev
Año:
2021
Tipo del documento:
Article
País de afiliación:
Estados Unidos